Alberca Ricardo Wesley, Lima Júlia Cataldo, de Oliveira Emily Araujo, Gozzi-Silva Sarah Cristina, Ramos Yasmim Álefe Leuzzi, Andrade Milena Mary de Souza, Beserra Danielle Rosa, Oliveira Luana de Mendonça, Branco Anna Cláudia Calvielli Castelo, Pietrobon Anna Julia, Pereira Nátalli Zanete, Teixeira Franciane Mouradian Emidio, Fernandes Iara Grigoletto, Duarte Alberto José da Silva, Benard Gil, Sato Maria Notomi
Laboratorio de Dermatologia e Imunodeficiencias (LIM-56), Departamento de Dermatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Front Physiol. 2021 Jan 27;11:637627. doi: 10.3389/fphys.2020.637627. eCollection 2020.
The severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, the COVID-19 pandemic presents a huge social and health challenge worldwide. Many different risk factors are associated with disease severity, such as systemic arterial hypertension, diabetes mellitus, obesity, older age, and other co-infections. Other respiratory diseases such as chronic obstructive pulmonary disease (COPD) and smoking are common comorbidities worldwide. Previous investigations have identified among COVID-19 patients smokers and COPD patients, but recent investigations have questioned the higher risk among these populations. Nevertheless, previous reports failed to isolate smokers and COPD patients without other comorbidities. We performed a longitudinal evaluation of the disease course of smokers, former smokers, and COPD patients with COVID-19 without other comorbidities, from hospitalization to hospital discharge. Although no difference between groups was observed during hospital admission, smokers and COPD patients presented an increase in COVID-19-associated inflammatory markers during the disease course in comparison to non-smokers and former smokers. Our results demonstrated that smoking and COPD are risk factors for severe COVID-19 with possible implications for the ongoing pandemic.
名为2019冠状病毒病(COVID-19)的严重呼吸道和全身性疾病由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起。目前,COVID-19大流行在全球范围内带来了巨大的社会和健康挑战。许多不同的风险因素与疾病严重程度相关,如系统性动脉高血压、糖尿病、肥胖、高龄以及其他合并感染。其他呼吸道疾病,如慢性阻塞性肺疾病(COPD)和吸烟,是全球常见的合并症。先前的调查在COVID-19患者中发现了吸烟者和COPD患者,但最近的调查对这些人群中较高的风险提出了质疑。然而,先前的报告未能分离出无其他合并症的吸烟者和COPD患者。我们对无其他合并症的COVID-19吸烟者、既往吸烟者和COPD患者从住院到出院的病程进行了纵向评估。虽然在入院期间未观察到组间差异,但与非吸烟者和既往吸烟者相比,吸烟者和COPD患者在病程中COVID-19相关炎症标志物有所增加。我们的结果表明,吸烟和COPD是严重COVID-19的风险因素,可能对当前的大流行产生影响。